Back to immortality: the restoration of embryonic telomere length during induced pluripotency

Bibliography

• 1  Weismann A: Essays Upon Heredity and Kindred Biological Problems (Volume I). Clarendon Press, UK (1891).
  Google Scholar
• 2  McLaren A: Embryology: the quest for immortality. Nature359,482–483 (1992).
  Medline CASGoogle Scholar
• 3  McLaren A: Mammalian germ cells: birth, sex, and immortality. Cell Struct. Funct.26,119–122 (2001).
  Medline CASGoogle Scholar
• 4  Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp. Cell Res.25,585–621 (1961).
  Medline CASGoogle Scholar
• 5  Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res.37,614–636 (1965).
  Medline CASGoogle Scholar
• 6  Hayflick L: Aging, longevity, and immortality in vitro. Exp. Gerontol.27,363–368 (1992).
  Medline CASGoogle Scholar
• 7  Olovnikov AM: Principles of marginotomy in template synthesis of polynucleotides. Dokl. Akad. Nauk SSSR201,1496–1499 (1971).
  Medline CASGoogle Scholar
• 8  Feng J, Funk WD, Wang S-S et al.: The RNA component of human telomerase. Science269,1236–1241 (1995).
  Medline CASGoogle Scholar
• 9  Nakamura TM, Morin GB, Chapman KB et al.: Telomerase catalytic subunit homologs from fission yeast and human. Science277,955–959 (1997).
  Medline CASGoogle Scholar
• 10  Bodnar AG, Ouellette M, Frolkis M et al.: Extension of cell life-span by introduction of telomerase into normal human cells. Science279,349–352 (1998).
  Medline CASGoogle Scholar
• 11  Vaziri H, Benchimol S: Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol.8,279–282 (1998).
  Medline CASGoogle Scholar
• 12  West MD: Embryonic stem cells: prospects of regenerative medicine for the treatment of human aging. In: The Future of Aging. Fahy GM, West MD, Coles LS, Harris SB (Eds). Springer, New York, USA, 451–487 (2010) (In Press).
  Google Scholar
• 13  Shawi M, Autexier C: Telomerase, senescence, and ageing. Mech. Ageing Dev.129,3–10 (2008).
  Medline CASGoogle Scholar
• 14  Shay JW, Wright WE: Use of telomerase to create bioengineered tissues. Ann. NY Acad. Sci.1057,479–491 (2005).
  Medline CASGoogle Scholar
• 15  Huang Q, Chen M: Improving cell therapy: experiments using transplanted telomerase-immortalized cells in immunodeficient mice. Mech. Ageing Dev.128(1),25–30 (2007).
  Medline CASGoogle Scholar
• 16  Kim NW, Piatyszek MA, Prowse KR et al.: Specific association of human telomerase activity with immortal cells and cancer. Science266,2011–2014 (1994).
  Medline CASGoogle Scholar
• 17  Thomson JA, Itskovitx-Eldor J, Shapiro SS: Embryonic stem cell lines derived from human blastocysts. Science282,1145–1147 (1998).
  Medline CASGoogle Scholar
• 18  Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH: Viable offspring derived from fetal and adult mammalian cells. Nature385(6619),810–813 (1997).
  Medline CASGoogle Scholar
• 19  Lanza RP, Cibelli JB, West MD: Prospects for the use of nuclear transfer in human transplantation. Nat. Biotechnol.17(12),1171–1174 (1999).
  Medline CASGoogle Scholar
• 20  Lanza RP, Cibelli JB, West MD: Human therapeutic cloning. Nat. Med.5(9),975–977 (1999).
  Medline CASGoogle Scholar
• 21  Shiels PG, Kind AJ, Campbell KH et al.: Analysis of telomere lengths in cloned sheep. Nature399(6734),316–317 (1999).
  Medline CASGoogle Scholar
• 22  Lanza RP, Cibelli JB, Blackwell C et al.: Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science288,665–669 (2000).
  Medline CASGoogle Scholar
• 23  Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131,861–872 (2007).
  Medline CASGoogle Scholar
• 24  Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science318,1917–1920 (2007).
  Medline CASGoogle Scholar
• 25  Marion RM, Strati K, Li H et al.: Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell4(2),141–154 (2009).
  Medline CASGoogle Scholar
• 26  Suhr ST, Chang EA, Rodriguez RM et al.: Telomere dynamics in human cells reprogrammed to pluripotency. PLoS One4(12),e8124 (2009).
  MedlineGoogle Scholar
• 27  Feng Q, Lu S-J, Klimanskaya I et al.: Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion an early senescence. Stem Cells28(4),704–712 (2010).
  MedlineGoogle Scholar
• 28  Agarwal S, Loh YH, McLoughlin EM et al.: Telomere elongation in induced pluripotent stem cells from dyskeratosis congenital patients. Nature464(7286),292–296 (2010).
  Medline CASGoogle Scholar
• 29  Vaziri H, Chapman K, Guigova A et al.: Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming. Regen. Med.5(3),345–363 (2010).
  CASGoogle Scholar
• 30  Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB: Telomere end-replication problem and cell aging. J. Mol. Biol.225,951–960 (1992).
  Medline CASGoogle Scholar
• 31  Riethman H, Ambrosini A, Paul S: Human subtelomere structure and variation. Chrom. Res.13(5),505–515 (2005).
  Medline CASGoogle Scholar
• 32  Chiu CP: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells14,239–248 (1996).
  Medline CASGoogle Scholar
• 33  Allsopp RC: Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA89,10114–10118 (1992).
  Medline CASGoogle Scholar
• 34  Binet R, Ythier D, Robles AI et al.: WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res.69(24),9183–9191 (2009).
  Medline CASGoogle Scholar
• 35  Hu BY, Weick JP, Yu J et al.: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA107(9),4335–4340 (2010).
  Medline CASGoogle Scholar
• 36  Pipes BL, Tsang T, Peng SX, Fiederlein R, Graham M, Harris DT: Telomere length changes after umbilical cord blood transplant. Transfusion46(6),1038–1043 (2006).
  Medline CASGoogle Scholar
• 37  Schatteman GC, Ma N: Old bone marrow cells inhibit skin wound vascularization. Stem Cells24(3),717–721 (2006).
  MedlineGoogle Scholar
• 38  Le Douarin NM: Ontogeny of the peripheral nervous system from the neural crest and the placodes: a developmental model studied on the basis of the quail-chick chimaera system. Harvey Lect.80,137–186 (1984).
  MedlineGoogle Scholar